Nuwellis, Inc.

NUWE Nasdaq SEC CIK 1506492
Follow Nuwellis Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2026 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26--
FY25$8.3M−$17.5M
FY24$8.7M−$11.2M
FY23$8.9M−$20.2M
FY22$8.5M−$14.5M
FY21$7.9M−$19.6M
FY20$7.4M−$15.8M
FY19$5.5M−$18.1M
FY18$5M−$17M
FY17$3.6M−$13.4M
FY16$1.3M−$15.8M
FY15$59K−$26.6M
FY14$295K−$25.6M
FY13$59K−$21.8M
FY12$0−$14.1M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−60000%−40000%−20000%0%20000%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY26---
FY2562%−134.3%−211.9%
FY2464.9%−125.7%−127.7%
FY2356.2%−198.9%−228%
FY2255.7%−201%−170%
FY2156.7%−246.5%−246.9%
FY2054.5%−228.8%−212.8%
FY1951.7%−328.5%−328.7%
FY1826.6%−340.9%−340.8%
FY1722.2%−416.9%−376.6%
FY1644.7%−1215.1%−1225.1%
FY15-−43996.6%−45055.9%
FY14-−8741.4%−8673.6%
FY13-−38764.4%−36878%
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26-
FY25−$10.9M
FY24−$9.7M
FY23−$18.1M
FY22−$15.3M
FY21−$18.1M
FY20−$16.9M
FY19−$16.9M
FY18−$14.8M
FY17−$12.2M
FY16−$16.4M
FY15−$23.2M
FY14−$23M
FY13−$17.7M
FY12−$13.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Nuwellis
  • Healthcare median
−60000%−40000%−20000%0%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearNuwellisHealthcare median
FY26-−11.1%
FY25−211.9%−30.6%
FY24−127.7%−47%
FY23−228%−58%
FY22−170%−80.4%
FY21−246.9%−71.8%
FY20−212.8%−62.2%
FY19−328.7%−46.2%
FY18−340.8%−49.6%
FY17−376.6%−45.9%
FY16−1225.1%−36%
FY15−45055.9%−37.8%
FY14−8673.6%−35.5%
FY13−36878%−37.1%
FY12-−29.1%